Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pleural Effusion, Malignant 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

pembrolizumab 2Hyperthermic Intraperitoneal Chemotherapy 2Gemcitabine 2Cisplatin 2niraparib 1dostarlimab 1defactinib 1Vitamin B 12 1TroVax 1Thiostrepton 1Sorafenib 1Pemetrexed 1Oxaliplatin 1Nivolumab 1Mitomycin 1MAC321 1Leucovorin 1Immunotherapy, Adoptive 1Imatinib Mesylate 1IPI-549 1Folic Acid 1Dexamethasone 1Cytoreduction Surgical Procedures 1Bortezomib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mesothelioma × Thiostrepton × Clear all
NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

RS Oncology LLC

Phase 1/2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡